Growth debt signals Claret Capital Partners is a growing, independent growth debt fund manager with a track record of investing over €1.2 billion across more than 200 SMEs in technology, life sciences, and impact sectors, indicating strong deal flow and potential for high-value partnerships.

Portfolio expansion Recent investments in Cinclus Pharma, SIS Medical (200th portfolio company), Deciphex, and Yseop demonstrate active portfolio expansion in life sciences, AI-enabled pathology, and Generative AI for life sciences, suggesting opportunities to cross-sell additional debt facilities and growth support.

Award-winning credibility Recognition as Venture Debt Provider of the Year at the Growth Investor Awards reinforces market credibility, which can shorten sales cycles and help in opening negotiations with growth-stage tech, biotech, and AI companies seeking scalable debt solutions.

Tech-enabled reach A tech stack featuring Drupal, MySQL, Mailchimp, PWA, and Cloudflare Bot Management implies modern, scalable go-to-market capabilities and the potential to engage portfolio and target companies through targeted digital campaigns and data-driven outreach.

Revenue opportunity With revenue in the range of one to ten million dollars and a sizable fund manager with global reach, there is a clear opportunity to structure additional growth debt facilities and strategic partnerships for mid-market technology, life sciences, and impact-focused companies seeking expansion capital.